Analyst downgraded Auna S.A. from Overweight to Neutral and set a new price target of $6.00
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/21/2026 | $6.90 | Hold → Buy | HSBC Securities |
| 1/16/2026 | $9.00 | Buy | Jefferies |
| 11/18/2025 | $6.00 | Overweight → Neutral | Analyst |
| 5/22/2025 | $7.90 | Buy → Hold | HSBC Securities |
| 4/23/2024 | $12.60 | Buy | HSBC Securities |
| 4/16/2024 | $16.00 | Overweight | JP Morgan |
| 4/16/2024 | $14.00 | Overweight | Morgan Stanley |
Auna S.A. ("Auna" or the "Company") (NYSE:AUNA), a Latin American healthcare company with operations in Mexico, Peru and Colombia, announced today the filing of its Annual Report on Form 20-F for the fiscal year ended December 31, 2025, with the Securities and Exchange Commission (the "SEC") on April, 21, 2026. Auna's Annual Report on Form 20-F can be accessed by visiting either the SEC's website at www.sec.gov or the "Financial Info" section of the Company's Investor Relations website at www.aunainvestors.com. In addition, shareholders may receive a hard copy of the Company's audited financial statements, or its complete 2025 Form 20-F including audited financial statements, free of char
Auna S.A. (NYSE:AUNA) ("Auna" or the "Company"), a leading healthcare services platform in Latin America with operations in Mexico, Peru, and Colombia, today reported select operating metrics for the First Quarter ended March 31, 2026. The Company intends to publish these key performance indicators on a quarterly basis going forward, as part of its commitment to providing investors with more information and a clearer understanding of Auna. Preliminary Key Performance IndicatorsAs of first quarter ended March 31, 2026 Healthcare Services Mexico Key Operating Metrics 1Q'25 2Q'25 3Q'25 4Q'25 1Q'26
Auna S.A. (NYSE:AUNA) ("Auna" or "the Company"), a leading Latin American healthcare services and plan provider with operations in Mexico, Peru and Colombia, announced today the reporting dates for its First Quarter 2026 financial results. Earnings Release Tuesday, May 19, 2026 Time: After Market Close Conference Call Wednesday, May 20, 2026 Time: 8:00 a.m. ET Quiet Period Monday, May 4 through Tuesday May 19, 2026 To participate, please dial +1 888 596 4144 (Toll-Free) +1 646 968 2525 (International) Entry Passcode: 3884034 Webcast: click here About Auna Auna is a leading horizontally and vertically integrated healthcare platform in Latin America with operatio
3 - AUNA S.A. (0001799207) (Issuer)
3/A - AUNA S.A. (0001799207) (Issuer)
3 - AUNA S.A. (0001799207) (Issuer)
HSBC Securities upgraded Auna S.A. from Hold to Buy and set a new price target of $6.90
Jefferies initiated coverage of Auna S.A. with a rating of Buy and set a new price target of $9.00
Analyst downgraded Auna S.A. from Overweight to Neutral and set a new price target of $6.00
6-K - AUNA S.A. (0001799207) (Filer)
SCHEDULE 13G/A - AUNA S.A. (0001799207) (Subject)
20-F - AUNA S.A. (0001799207) (Filer)
Auna S.A. (NYSE:AUNA) ("Auna" or "the Company"), a leading Latin American healthcare services and plan provider with operations in Mexico, Peru and Colombia, announced today the reporting dates for its First Quarter 2026 financial results. Earnings Release Tuesday, May 19, 2026 Time: After Market Close Conference Call Wednesday, May 20, 2026 Time: 8:00 a.m. ET Quiet Period Monday, May 4 through Tuesday May 19, 2026 To participate, please dial +1 888 596 4144 (Toll-Free) +1 646 968 2525 (International) Entry Passcode: 3884034 Webcast: click here About Auna Auna is a leading horizontally and vertically integrated healthcare platform in Latin America with operatio
Auna Closes FY 2025 with Strong Performance in Peru and Colombia and 35% increase in Free Cash Flow Signs of Recovery in Mexico in 2026 Company Sets 12% Adjusted EBITDA Growth Guidance for 2026 Auna (NYSE:AUNA) ("Auna" or the "Company"), a leading healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, announced today financial results for the fourth quarter ended December 31, 2025 ("fourth quarter 2025" or "4Q25") and full-year ended 2025 ("full-year 2025" or "FY25"). Financial results are expressed in Peruvian Soles ("S/" or "PEN") and are presented in accordance with International Financial Reporting Standards ("IFRS"), unless otherwise noted. FY25 Conso
Auna S.A. (NYSE:AUNA) ("Auna" or "the Company"), a leading Latin American healthcare services and plan provider with operations in Mexico, Peru and Colombia, announced today the reporting dates for its Fourth Quarter and Full-Year 2025 financial results. Earnings Release Tuesday, March 10, 2026 Time: After Market Close Conference Call Wednesday, March 11, 2026 Time: 8:00 a.m. ET Quiet Period Monday, February 23 through Tuesday, March 10, 2026 To participate, please dial +1 888 596 4144 (Toll-Free) +1 646 968 2525 (International) Entry Passcode: 3884034 Webcast: click here About Auna Auna is a leading horizontally and vertically integrated healthcare platform in
SC 13G - AUNA S.A. (0001799207) (Subject)
SC 13G/A - AUNA S.A. (0001799207) (Subject)
SC 13G - AUNA S.A. (0001799207) (Subject)
Auna S.A. (NYSE:AUNA) ("Auna" or the "Company"), a Latin American healthcare company with operations in Mexico, Peru, and Colombia, announced today the signing of an exclusive five-year agreement with a physician group practicing at Organización Para Cuidado Integral en Oncología, S.A. de C.V. known as Opción Oncología, the premier oncology ambulatory clinic in Monterrey. This strategic partnership strengthens Auna's commitment to becoming the leading oncology provider in Mexico and marks a significant step in consolidating oncology services within Auna Mexico. As part of this agreement, eight highly regarded physicians – six oncologists and two radiation oncologists – will join Auna. Toda
Auna S.A. (NYSE:AUNA) ("Auna" or the "Company"), a leading Latin American healthcare company operating in Mexico, Peru, and Colombia, today announced the appointment of two new independent directors, Teresa Gutierrez and Guadalupe Phillips, to its Board of Directors, effective January 1, 2025. Ms. Gutierrez is responsible for Tesla in Mexico. Prior to that, she held positions at Rappi, Mattel, Nestle, McKinsey, and Procter and Gamble. She serves on the boards of several public and private companies, including Traxion, DIRI, Vetalia, and Timser. Ms. Phillips is the Chief Executive Officer of ICA, a prominent construction and infrastructure company in Mexico after a long career holding se
Auna S.A. (NYSE:AUNA) ("Auna" or the "Company"), a Latin American healthcare company with operations in Mexico, Peru and Colombia, announced today the appointment of Laurent "Lorenzo" Massart as Executive Vice President, Strategy and Equity Capital Markets to its executive team. "We are thrilled to welcome Lorenzo to the Auna team. With over 25 years of experience in consulting and investment banking, he brings a wealth of knowledge and expertise to this newly created role. He has been a key and trusted advisor in our strategic endeavors and has worked closely with me and Auna for the last three years, playing an integral part of our journey into Mexico and on becoming a public company,"